HAMBURG, Germany -- Faster-acting insulin aspart was safe for pregnant women with type 1 or 2 diabetes and resulted in fewer events of hypoglycemia, the randomized CopenFast trial found. The mean ...
Participants using aspart and faster aspart had similar characteristics. Most patients only used 1 smart pen to administer either aspart (n = 406) or faster aspart (n = 417). A further 25% (n = 300) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback